Acciones BetterLife Pharma Inc. Other OTC
Acciones
BETRF
CA08772P2026
Biotecnología e investigación médica
Ventas 2022 | - | Ventas 2023 | - | Capitalización | 13,32 M 12,24 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -12 M -11,03 M | Resultado Neto 2023 | -9 M -8,28 M | VE / Ventas 2022 | - |
Deuda neta 2022 | 139 mil 128 mil | Deuda neta 2023 | 71,69 mil 65,92 mil | VE / Ventas 2023 | - |
P/E ratio 2022 |
-1,26
x | P/E ratio 2023 |
-1,36
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 77,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/12/10 |
Chief Operating Officer | 67 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/09/07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/01/20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/02/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,52 % | 113 mil M | |
+11,38 % | 106 mil M | |
-12,64 % | 22,22 mil M | |
+0,44 % | 22,27 mil M | |
-4,18 % | 19,43 mil M | |
-37,85 % | 17,87 mil M | |
-8,58 % | 17,24 mil M | |
+37,41 % | 12,52 mil M | |
-23,95 % | 8341,29 M |